{"related:xO7DSt2acJIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1102673","authors":["CATT Research Group"],"year":2011,"numCitations":2279,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1102673","citationUrl":"http://scholar.google.com/scholar?cites=10552104202161876676&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:xO7DSt2acJIJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10552104202161876676&hl=en&as_sdt=0,5","publication":"Mass Medical Soc","p":1,"exp":1596876834158},{"title":"Ranibizumab for neovascular age-related macular degeneration","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa054481","authors":["PJ Rosenfeld","PJ Rosenfeld DM Brown","PJ Rosenfeld DM Brown JS Heier…"],"year":2006,"numCitations":5539,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa054481","citationUrl":"http://scholar.google.com/scholar?cites=8974229375962153245&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:HYEZ5xHeinwJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8974229375962153245&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","url":"https://www.sciencedirect.com/science/article/pii/S0161642012003211","authors":["DF Martin","DF Martin MG Maguire","DF Martin MG Maguire SL Fine","DF Martin MG Maguire SL Fine G Ying","DF Martin MG Maguire SL Fine G Ying GJ Jaffe…"],"year":2012,"numCitations":1503,"pdf":"https://www.aaojournal.org/article/S0161-6420(12)00321-1/fulltext","citationUrl":"http://scholar.google.com/scholar?cites=10792614161104863546&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:OoGB1mURx5UJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10792614161104863546&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial","url":"https://www.sciencedirect.com/science/article/pii/S0161642012003582","authors":["U Chakravarthy","U Chakravarthy SP Harding","U Chakravarthy SP Harding CA Rogers","U Chakravarthy SP Harding CA Rogers SM Downes…"],"year":2012,"numCitations":750,"citationUrl":"http://scholar.google.com/scholar?cites=25259042646724407&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Nw9TKPe8WQAJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=25259042646724407&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","url":"https://www.sciencedirect.com/science/article/pii/S0161642012008652","authors":["JS Heier","JS Heier DM Brown","JS Heier DM Brown V Chong","JS Heier DM Brown V Chong JF Korobelnik…"],"year":2012,"numCitations":1639,"pdf":"https://www.aaojournal.org/article/S0161-6420(12)00865-2/fulltext","citationUrl":"http://scholar.google.com/scholar?cites=14219812270129551750&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:hhnQfevrVsUJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14219812270129551750&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa062655","authors":["DM Brown","DM Brown PK Kaiser","DM Brown PK Kaiser M Michels…"],"year":2006,"numCitations":3582,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa062655","citationUrl":"http://scholar.google.com/scholar?cites=9359055513483703514&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:2nRbMmcL4oEJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9359055513483703514&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study","url":"https://www.sciencedirect.com/science/article/pii/S0161642008010750","authors":["DM Brown","DM Brown M Michels","DM Brown M Michels PK Kaiser","DM Brown M Michels PK Kaiser JS Heier","DM Brown M Michels PK Kaiser JS Heier JP Sy…"],"year":2009,"numCitations":1319,"citationUrl":"http://scholar.google.com/scholar?cites=4074405506620367847&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:56MAnTgyizgJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4074405506620367847&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study","url":"https://www.sciencedirect.com/science/article/pii/S0002939409001020","authors":["GA Lalwani","GA Lalwani PJ Rosenfeld","GA Lalwani PJ Rosenfeld AE Fung","GA Lalwani PJ Rosenfeld AE Fung SR Dubovy…"],"year":2009,"numCitations":948,"pdf":"https://www.academia.edu/download/39898046/A_variable-dosing_regimen_with_intravitr20151111-31301-1bi6spj.pdf","citationUrl":"http://scholar.google.com/scholar?cites=11836556073092515452&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:fAasJAnlQ6QJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11836556073092515452&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673613615019","authors":["U Chakravarthy","U Chakravarthy SP Harding","U Chakravarthy SP Harding CA Rogers","U Chakravarthy SP Harding CA Rogers SM Downes…"],"year":2013,"numCitations":581,"pdf":"https://www.sciencedirect.com/science/article/pii/S0140673613615019","citationUrl":"http://scholar.google.com/scholar?cites=4406819954534910838&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:dgsoe2YrKD0J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4406819954534910838&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1","url":"https://www.sciencedirect.com/science/article/pii/S0002939407008811","authors":["CD Regillo","CD Regillo DM Brown","CD Regillo DM Brown P Abraham","CD Regillo DM Brown P Abraham H Yue…"],"year":2008,"numCitations":965,"pdf":"http://www.academia.edu/download/40619090/Randomized_Double-Masked_Sham-Controlled20151203-17633-voecqd.pdf","citationUrl":"http://scholar.google.com/scholar?cites=492233582111835518&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:fkVLwNXD1AYJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=492233582111835518&hl=en&as_sdt=0,5","publication":"Elsevier"}]}